Want to see PRE full AI Analyst Report?
PRE Stock Chart & Stats
$17.83
-$0.22(-3.97%)
At close: 4:00 PM EST
$17.83
-$0.22(-3.97%)
Day’s Range― - ―
52-Week Range$7.18 - $23.63
Previous CloseN/A
Volume5.03K
Average Volume (3M)217.59K
Market Cap
$350.54M
Enterprise Value$222.43
Total Cash (Recent Filing)$106.03M
Total Debt (Recent Filing)$457.00K
Price to Earnings (P/E)―
Beta0.21
Next Earnings
Sep 11, 2026EPS Estimate
-0.84Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.58
Shares Outstanding15,247,465
10 Day Avg. Volume320,271
30 Day Avg. Volume217,595
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)1.27
Price to Sales (P/S)2.40
P/FCF Ratio-10.05
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$37.00Price Target Upside107.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-3.26
Revenue Forecast (FY)$218.08M
Bulls Say, Bears Say
Bulls Say
Recurring SubscriptionsA subscription-driven revenue base (93% of IM8 revenue) with ~82k active subscribers and rising servings creates predictable, repeatable revenue and stronger LTV visibility. Durable subscription mix supports unit-economics scaling, reduces churn sensitivity, and improves forecastability as cohorts mature.
Margin ExpansionMeaningful gross margin improvement to ~64% reflects favorable mix toward subscriptions, scale manufacturing efficiencies, and packaging/fulfillment gains. Higher gross margins underpin sustainable operating leverage as revenue scales, improving the path to positive operating profit if SG&A growth moderates.
Liquidity & Non-dilutive FinancingAccess to a $1B non-dilutive, cohort‑linked facility plus realized BTC proceeds and ~$147M combined resources materially increases funding optionality. This preserves equity, funds scalable customer acquisition, and lowers near-term refinancing risk while management executes on international growth.
Bears Say
Multi-year Cash BurnSustained negative operating/free cash flow (multi-year) indicates the business is cash‑consumptive while scaling. Even with recent liquidity, ongoing cash burn raises reliance on external financing or asset sales, increasing execution risk if unit economics or growth rates slip before break‑even is reached.
Persistent Operating LossesDespite strong top‑line and gross margin gains, the company remains deeply unprofitable with wide negative margins. Prolonged value destruction reduces return on equity and means scale must be large and sustained to absorb fixed costs and marketing before shareholders see durable profitability.
Marketing/channel ConcentrationHeavy reliance on a single ad platform (roughly 85% Meta) and large marketing outlays make growth vulnerable to rising CAC or platform policy changes. Early-stage tests on TikTok/YouTube have limited spend, so successful channel diversification is unproven and material to sustaining current cohort economics.
Prenetics Group News
PRE FAQ
What was Prenetics Group Limited’s price range in the past 12 months?
Prenetics Group Limited lowest stock price was $7.17 and its highest was $23.63 in the past 12 months.
What is Prenetics Group Limited’s market cap?
Prenetics Group Limited’s market cap is $350.54M.
When is Prenetics Group Limited’s upcoming earnings report date?
Prenetics Group Limited’s upcoming earnings report date is Sep 11, 2026 which is in 51 days.
How were Prenetics Group Limited’s earnings last quarter?
Prenetics Group Limited released its earnings results on May 14, 2026. The company reported -$1.36 earnings per share for the quarter, missing the consensus estimate of -$1.017 by -$0.343.
Is Prenetics Group Limited overvalued?
According to Wall Street analysts Prenetics Group Limited’s price is currently Undervalued.
Does Prenetics Group Limited pay dividends?
Prenetics Group Limited pays a Quarterly dividend of $0.7 which represents an annual dividend yield of N/A. See more information on Prenetics Group Limited dividends here
What is Prenetics Group Limited’s EPS estimate?
Prenetics Group Limited’s EPS estimate is -0.84.
How many shares outstanding does Prenetics Group Limited have?
Prenetics Group Limited has 15,247,465 shares outstanding.
What happened to Prenetics Group Limited’s price movement after its last earnings report?
Prenetics Group Limited reported an EPS of -$1.36 in its last earnings report, missing expectations of -$1.017. Following the earnings report the stock price went up 0.114%.
Which hedge fund is a major shareholder of Prenetics Group Limited?
Currently, no hedge funds are holding shares in PRE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Prenetics Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$37.00 (107.52% Upside)
$37.00 (107.52% Upside)
Blogger Sentiment
Bullish
PRE Sentiment 70%
Sector Average 63%
Sector Average 63%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.5%
Last 30 Days ▼ 8.1%
Last 30 Days ▼ 8.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
173.12%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-14.07%
Trailing 12-Months
Company Description
Prenetics Group Limited
As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, a consumer-oriented genetic analysis solution, and the Circle HealthPod, an advanced health monitoring device. The Circle HealthPod facilitates rapid COVID-19 detection through nucleic acid amplification technology, suitable for both professional point-of-care and personal at-home use. Additionally, the company offers ColoClear, a non-invasive FIT-DNA screening test for colorectal cancer, and Circle SnapShot, a readily available at-home blood testing kit. Other diagnostic solutions in their portfolio include Circle Medical, Circle One, and F1x/Fem. Prenetics Global Limited was founded in 2014 and maintains its headquarters in Quarry Bay, Hong Kong.
PRE Stock 12 Month Forecast
Average Price Target
$37.00
▲(107.52% Upside)
Technical Analysis
Ownership Overview
0.70% Insiders
0.04% Mutual Funds
7.00% Other Institutional Investors
92.26% Public Companies and
Individual Investors











